Medical Prognosis Institute A/S - Passing of Annual General Meeting
ET | Source:Medical Prognosis Institute
Hoersholm; April 24. 2014 - On Thursday 24 April 2014 at 4.30 p.m., the annual
general meeting of Medical Prognosis Institute A/S was held with the following
1. Election of the Chairman of the annual general meeting
2. The board of directors' report on the company's activities during the past
3. Motion from the board of directors to prepare and present the annual report
only in English
4. Presentation of the annual accounts with the auditors' report for adoption
5. Resolution on appropriation of profits or payment of loss in accordance
with the adopted annual accounts
6. Election of the board of directors
7. Appointment of auditor
8. Motion from the board of directors to increase in cash the company's share
capital at the market price by minimum nominally DKK 50,000 and maximum
nominally DKK 84,000 from nominally DKK 951,372 to a total of minimum
nominally DKK 1,001,372 and maximum nominally DKK 1,035,372 by a direct
placement without any pre-emption right to existing shareholders, including
a motion to amend the company's Articles of Association accordingly.
9. Motion from the board of directors to adopt a new authorisation to issue
warrants and any relating capital increases, including a motion to amend
the company's Articles of Association accordingly.
10. Authorisation to the chairman of the annual general meeting
11. Any other business
Re item 1
In accordance with article 10.2 of the company's articles of association, the
board of directors appointed Attorney-at-Law Thomas Holst Laursen to chair the
annual general meeting.
Re item 2
The general meeting adopted the report of the board of directors.
Re item 3
The proposal by the board of directors to prepare and present the annual report
of the company in English only was approved by the general meeting, and a
provision in this respect was incorporated in the company's articles of
Re item 4
The general meeting adopted the 2013 annual accounts.
Re item 5
The general meeting approved the proposed payment of loss in accordance with the
adopted annual accounts.
Re item 6
Jørgen Søberg Petersen, Niels Johansen, Peter Buhl and Steen Meier Knudsen were
re-elected to the board of directors, and Magnus Persson was elected as a new
member of the board of directors.
Re item 7
The general meeting re-elected PricewaterhouseCoopers Statsautoriseret
Revisionspartnerselskab as the company's auditor.
Re item 8
The general meeting approved the proposal to increase in cash the company's
share capital at the market price by minimum nominally DKK 50,000 and maximum
nominally DKK 84,000 from nominally DKK 951,372 to a total of minimum nominally
DKK 1,001,372 and maximum nominally DKK 1,035,372 by a direct placement without
any pre-emption right to existing shareholders as well as the proposal to amend
the company's articles of association in accordance therewith.
Re item 9
The general meeting authorised the board of directors - in the period until 24
April 2019 - to decide once or several times to issue warrants to subscribe for
shares of up to nominally DKK 95,000 and to decide on the relating capital
increase. The warrants may be issued to the company's key employees, members of
the board of directors and any other key figures. In connection therewith, the
general meeting resolved to incorporate the authorisation in the company's
articles of association.
Re item 10
The general meeting authorised the chairman of the general meeting to register
the resolutions with the Danish Business Authority.
For further information please contact
Peter Buhl Jensen, CEO
Cell Phone: (+45) 21 60 89 22
Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen
44, 2900 Hellerup, Denmark
other press releases byMedical Prognosis Institute
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454